Compare MGTX & BFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MGTX | BFS |
|---|---|---|
| Founded | 2015 | 1993 |
| Country | United States | United States |
| Employees | N/A | 98 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 909.1M | 809.1M |
| IPO Year | 2018 | N/A |
| Metric | MGTX | BFS |
|---|---|---|
| Price | $9.63 | $33.76 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | $24.57 | ★ $44.00 |
| AVG Volume (30 Days) | ★ 686.8K | 42.0K |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 6.92% |
| EPS Growth | ★ 33.02 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $81,391,000.00 | N/A |
| Revenue This Year | $141.38 | $0.30 |
| Revenue Next Year | N/A | $5.67 |
| P/E Ratio | ★ N/A | $30.48 |
| Revenue Growth | ★ 144.57 | N/A |
| 52 Week Low | $5.02 | $29.16 |
| 52 Week High | $11.85 | $35.45 |
| Indicator | MGTX | BFS |
|---|---|---|
| Relative Strength Index (RSI) | 51.51 | 48.63 |
| Support Level | $7.13 | $33.14 |
| Resistance Level | $9.65 | $34.99 |
| Average True Range (ATR) | 0.48 | 0.76 |
| MACD | -0.08 | -0.11 |
| Stochastic Oscillator | 49.22 | 42.29 |
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy. The company's pipeline is supported by end-to-end in-house manufacturing capabilities, including GMP viral vector production, plasmid manufacturing, and quality control, enabling development from IND to commercial supply. It also utilizes proprietary platforms in viral vector optimization and riboswitch-based gene regulation to enhance efficacy and reduce dosage. The company operates in the United States, the United Kingdom, and the European Union.
Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: Shopping Centers segment, which contribute the maximum portion of total revenue; and mixed-use properties.Mixed-Use Properties segment include office, retail and multi-family residential use.